The French dermo-cosmetic manufacturer aims to identify predictive biomarkers of skin aging to drive the development of new products for its Eau Thermale Avène brand.
Pierre Fabre has entered a five-year sponsorship agreement with the Hospital-University Institute (IHU) HealthAge at the University Hospital Center of Toulouse, France. This long-standing partnership, first initiated in 2012 with the team led by Professor Bruno Vellas, founding President of IHU HealthAge, aims to enhance the treatment of early signs of skin aging.
Pierre Fabre is making strides in researching skin aging biomarkers, particularly through its research program launched in 2020 as part of the INSPIRE T cohort. This program follows over 1,000 volunteers, aged 20 to 100, over a ten-year period to study the biological processes linked to skin aging.
“We took advantage of the INSPIRE T cohort to establish a unique research program on skin aging with the CHU of Toulouse, Toulouse III-Paul Sabatier University, and Inserm, co-founders of the IHU HealthAge. The initial results obtained are very promising and represent an important step in understanding the biological mechanisms underlying skin aging,” shares Sandrine Bessou Touya, Director of Applied Research at Pierre Fabre Dermo-Cosmetics. Pierre Fabre is making strides in researching skin aging biomarkers, pushing the boundaries of scientific understanding.
New Product Developments for Avène Pierre Fabre Laboratories plan to leverage these findings to improve how they address skin aging through product innovations. The collaboration with IHU HealthAge is expected to identify predictive biomarkers of aging and the transition to skin fragility. These biomarkers may help determine a person’s biological age, which often differs from their chronological age.
Pierre Fabre is making strides in researching skin aging biomarkers, laying the groundwork for future innovations. According to the Group, this medical research will allow the development of personalized, preventive skin care capable of delaying or even reversing the first signs of aging.
The company plans to apply these medical advancements to its renowned Eau Thermale Avène brand, with new product developments aimed at addressing skin aging. Pierre Fabre is making strides in researching skin aging biomarkers, which will likely influence the next generation of skincare treatments.
